 | • レポートコード：MRC2304F017 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、228ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートによると、2021年に4,017.70百万ドルであった世界の陰圧閉鎖療法（NPWT）市場規模は2022年に4,303.87百万ドルになり、更に年平均7.29％拡大して2027年までに6,131.48百万ドルに達する見通しです。本書は、陰圧閉鎖療法（NPWT）の世界市場についての多面的な調査を元に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（従来型NPWT、使い捨てNPWT）分析、創傷タイプ別（やけど、糖尿病性足潰瘍、褥瘡、静脈性下肢潰瘍）分析、エンドユーザー別（在宅医療、病院）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの内容をまとめた市場調査レポートです。なお、本書に掲載されている企業情報には、4l Health、Acelity L.P. Inc、Alleva Medical、Applied Tissue Technologies (ATT)、Avery Dennison Corporation、Cardinal Health、Carilex Medical GmbH、Chongqing Sunshine Medical Industry And Trading Co.Ltd、Convatec Group、Cork Medical LLCなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の陰圧閉鎖療法（NPWT）市場規模：製品別 - 従来型NPWTの市場規模 - 使い捨てNPWTの市場規模 ・世界の陰圧閉鎖療法（NPWT）市場規模：創傷タイプ別 - やけどにおける市場規模 - 糖尿病性足潰瘍における市場規模 - 褥瘡における市場規模 - 静脈性下肢潰瘍における市場規模 ・世界の陰圧閉鎖療法（NPWT）市場規模：エンドユーザー別 - 在宅医療における市場規模 - 病院における市場規模 ・世界の陰圧閉鎖療法（NPWT）市場規模：地域別 - 南北アメリカの陰圧閉鎖療法（NPWT）市場規模 アメリカの陰圧閉鎖療法（NPWT）市場規模 カナダの陰圧閉鎖療法（NPWT）市場規模 ブラジルの陰圧閉鎖療法（NPWT）市場規模 ... - アジア太平洋の陰圧閉鎖療法（NPWT）市場規模 日本の陰圧閉鎖療法（NPWT）市場規模 中国の陰圧閉鎖療法（NPWT）市場規模 インドの陰圧閉鎖療法（NPWT）市場規模 韓国の陰圧閉鎖療法（NPWT）市場規模 台湾の陰圧閉鎖療法（NPWT）市場規模 ... - ヨーロッパ/中東/アフリカの陰圧閉鎖療法（NPWT）市場規模 イギリスの陰圧閉鎖療法（NPWT）市場規模 ドイツの陰圧閉鎖療法（NPWT）市場規模 フランスの陰圧閉鎖療法（NPWT）市場規模 ロシアの陰圧閉鎖療法（NPWT）市場規模 ... - その他地域の陰圧閉鎖療法（NPWT）市場規模 ・競争状況 ・企業情報 |
The Global Negative Pressure Wound Therapy Market size was estimated at USD 4,017.70 million in 2021 and expected to reach USD 4,303.87 million in 2022, and is projected to grow at a CAGR 7.29% to reach USD 6,131.48 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Negative Pressure Wound Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Conventional NPWT and Single-use NPWT.
Based on Wound Type, the market was studied across Burn Wounds, Diabetic Foot Ulcers, Pressure Ulcers, and Venous Leg Ulcers.
Based on End User, the market was studied across Homecare and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Negative Pressure Wound Therapy market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Negative Pressure Wound Therapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Negative Pressure Wound Therapy Market, including 4l Health, Acelity L.P. Inc, Alleva Medical, Applied Tissue Technologies (ATT), Avery Dennison Corporation, Cardinal Health, Carilex Medical GmbH, Chongqing Sunshine Medical Industry And Trading Co.Ltd, Convatec Group, Cork Medical LLC, Deroyal Industries, Galaxy Medical Products, Inc., Genadyne Biotechnologies Inc, Haromed Bvba, Infusystem Holdings Inc, Lohmann & Rauscher International, McKesson Corporation, Medela, Mölnlycke Health Care Ab, Norco Inc., Paul Hartmann Ag, Pensar Medical, Smith & Nephew Plc, Talley Group, Triage Meditech, and Wuhan Vsd Medical Science & Technology.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Negative Pressure Wound Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Negative Pressure Wound Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Negative Pressure Wound Therapy Market?
4. What is the competitive strategic window for opportunities in the Global Negative Pressure Wound Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global Negative Pressure Wound Therapy Market?
6. What is the market share of the leading vendors in the Global Negative Pressure Wound Therapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Negative Pressure Wound Therapy Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of chronic diseases and geriatric population
5.1.1.2. High demand for advanced wound care
5.1.1.3. Increasing occurrences of cesarean sections in elderly mothers
5.1.2. Restraints
5.1.2.1. High cost of NPWT device
5.1.3. Opportunities
5.1.3.1. Favorable reimbursement coverage in various economies
5.1.3.2. Focused R&D efforts for the advancements in NPWT
5.1.4. Challenges
5.1.4.1. Risk and complications associated with the therapy
5.2. Cumulative Impact of COVID-19
6. Negative Pressure Wound Therapy Market, by Product
6.1. Introduction
6.2. Conventional NPWT
6.3. Single-use NPWT
7. Negative Pressure Wound Therapy Market, by Wound Type
7.1. Introduction
7.2. Burn Wounds
7.3. Diabetic Foot Ulcers
7.4. Pressure Ulcers
7.5. Venous Leg Ulcers
8. Negative Pressure Wound Therapy Market, by End User
8.1. Introduction
8.2. Homecare
8.3. Hospitals
9. Americas Negative Pressure Wound Therapy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Negative Pressure Wound Therapy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Negative Pressure Wound Therapy Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 4l Health
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Acelity L.P. Inc
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Alleva Medical
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Applied Tissue Technologies (ATT)
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Avery Dennison Corporation
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cardinal Health
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Carilex Medical GmbH
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Chongqing Sunshine Medical Industry And Trading Co.Ltd
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Convatec Group
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Cork Medical LLC
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Deroyal Industries
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Galaxy Medical Products, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Genadyne Biotechnologies Inc
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Haromed Bvba
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Infusystem Holdings Inc
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Lohmann & Rauscher International
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. McKesson Corporation
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Medela
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Mölnlycke Health Care Ab
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Norco Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Paul Hartmann Ag
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Pensar Medical
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Smith & Nephew Plc
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Talley Group
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Triage Meditech
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. Wuhan Vsd Medical Science & Technology
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing